A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 61,400 shares of PLSE stock, worth $615,228. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,400
Holding current value
$615,228
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$7.8 - $11.02 $478,920 - $676,628
61,400 New
61,400 $535,000
Q3 2023

Nov 14, 2023

BUY
$4.03 - $8.73 $288,145 - $624,195
71,500 New
71,500 $288,000
Q2 2022

Aug 12, 2022

SELL
$1.48 - $4.28 $115,179 - $333,086
-77,824 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$4.21 - $14.79 $327,639 - $1.15 Million
77,824 New
77,824 $378,000
Q3 2021

Nov 12, 2021

SELL
$17.25 - $26.63 $687,447 - $1.06 Million
-39,852 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$16.31 - $23.64 $649,986 - $942,101
39,852 New
39,852 $654,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $372M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.